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National innovative capacity, a central driver of countries’ long-term economic growth, has been 
one of the focal points in innovation research for roughly thirty years. Initially proposed as an 
index to measure technologic invention over time, this concept has become the widely accepted 
standard for measuring the performance of (sub) national and sectoral innovation systems to-
ward being an analytic tool attributed to innovation systems theory. Country comparison, know-
ledge flows, and R&D forecasting are in the center of analysis feeding the concrete practical use 
of innovation policy optimization. In this regard, a rich body of studies has contributed indispen-
sable knowledge about the determinants of innovative capacity. However, the multi-dimensional 
interconnections have not been covered in depth. Thus, to gain a holistic understanding of the 
“DNA” behind national innovative capacity a new “comparative” view of these determinants is 
necessary. To this end, this dissertation proposes revisiting the focus, unit and parameters of 
analysis that predominate within current national innovative capacity studies and sets forth 
three interlinked academic articles that focus on different layers of innovative capacity in coun-
tries. Besides furthering academic discourse on the determinants of innovational outcome, this 
conceptual revision leads to a new approach on national innovation capacity research. Its in-
tention is to make policy makers aware of certain pathways leading to the same outcome. This 
knowledge will enable them to pursue a dynamic approach of supporting the innovative proces-
ses in countries by defining appropriate innovation strategies that consider both the countries’ 
specific preconditions and the sub-systems perspective.
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1. Introduction  
“
”
- Steve Jobs (1955-2011) - 
Not just since Steve Jobs and his wise statement on innovation has mankind been 
aware of innovation as the power that drives technical progress and economic 
growth (List and Colwell, 1856; Schumpeter, 1939; Solow, 1956).  
Innovation emanates from interaction and knowledge flows, and various systems 
of innovation shape manifold innovation processes. Innovative capacity refers to 
the level of invention and the potential for innovation in any nation, geographical 
area or economic activity (Villa, 1990), thereby reflecting “the ability […] to 
produce and commercialize a flow of innovative technology over the long term”
(Furman et al., 2002, p. 899)  Various innovative capacity comparisons can be 
found in both practical and academic backgrounds, not only comparing countries 
but also targeting regions, cities or industry sectors. Among them, the Global 
Innovation Index (Dutta et al., 2015) can be named as the most prominent 
evaluation of countries’ innovative capacity. The annual results of this far-
reaching study can even be found within the financial section of newspapers
1
 in 
the format of country rankings.  
In this connection, almost inevitably two questions arise. Firstly, how can 
innovation be measured? And secondly, why are some countries more innovative 
than others? These issues build the foundation of national innovation systems 
(NIS) theory, a highly important research stream within economic sciences 
(Albach, 2006). The terms “innovative capacity”, “innovation strategy” and 
“innovation policy” dominate the rhetoric in this scientific field (Acs et al., 2016; 
Sun and Grimes, 2016; Teixeira, 2014). In its core, the innovative capacity 
concept claims to offer an explanation of the several measurable determinants 
that influence the innovational outcome of a certain system, be it the whole state, 
1
  See e.g. Handelsblatt GmbH (2016): WirtschaftsWoche Online - Global Innovation Index 2016 - Das 
sind die innovativsten Länder der Welt. Retrieved from: http://www.wiwo.de/politik/ausland/global-
innovation-index-2016-das-sind-die-innovativsten-laender-der-welt/14017512.html (March 08, 2017) 
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an industry cluster or even a single company. This knowledge will enable 
legislators to define the right innovation  strategies and implement them with the 
help of appropriate innovation policies, the catalysts for innovative growth 
(Edquist, 2001, 2009, 2013, 2016; Johnson et al., 2003). Institutional changes, 
changes in economic incentives or the setting of new quantified targets are just a 
few means of these policy-based interventions.  
A consistent framework that includes a measurable indicator is necessary to 
apply innovation systems theory. With their “innovative capacity framework” 
Furman et al. contributed significantly to this crucial requirement in 2002. Their 
novel framework built upon earlier attempts to measure and explain innovational 
outcome. Derived from growth theory, these earlier innovation indexes intended 
to show the influence of technological change on economic growth and provided 
regular diagnostics of national performance in invention over time (Romer, 1986, 
1990; Solow, 1994; Villa, 1990). Besides drawing on ideas-driven growth theory, 
the Furman framework relies on two other distinct areas of prior research: the 
cluster-based theory of national industrial competitive advantage (Porter, 1990) 
and research on NIS (Nelson, 1993). From Furman on, the framework has been 
applied diverse contexts:  
 comparison of developed and developing countries (Dezhina and Etzkowitz, 
2016; Freeman, 2002; Hu and Mathews, 2005; Joshua, 2016; Krammer, 2009; 
Krstic et al., 2016; Marxt and Brunner, 2013; Nelson, 1992; Varblane, 2012; 
Varblane et al., 2007); 
 comprehension and explanation of knowledge processes (Guan and Chen, 
2012; Lundvall, 2007; Lundvall, 1998; Lundvall, 2010; Lundvall et al., 2002) 
and technology transfer (Hekkert and Negro, 2009; Mowery and Oxley, 1995; 
Paik et al., 2009); 
 assessment of efficiency as well as forecasting of R&D activity (Moon and 
Lee, 2005; Robinson et al., 2013; Wang and Huang, 2007). 
In this course of application, the innovative capacity framework (ICF) has been 
modified and incrementally enhanced by broadening the scope of the underlying 
concept (Castellacci and Natera, 2011, 2013; Faber and Hesen, 2004; Filippetti 
3 
and Peyrache, 2011; Furman and Hayes, 2004; Hu and Mathews, 2005; Lee and 
Kim, 2009). Besides the introduction and testing of new data sets, variables and 
statistical methods, other perspectives moved into the center of analysis: global 
innovation systems (Binz, C., Truffer, B., Coenen, L., 2016), regional innovation 
systems (Cooke, 2002) and local innovation systems (Martin and Simmie, 
2008).
2
 In addition to these alternative territories, the original idea has also been 
expanded from country comparison to the innovative output of industrial sectors 
(Malerba, 2002) or single technology areas (Bergek et al., 2015) such as 
biomaterials. However, this use is not yet a common practice. In any case, the 
methodology and goals of innovation systems research largely remain the same. 
The combination of elements of growth theory, the Schumpeterian school of 
thought and modern, systemic approaches to innovation pave the way to suitable 
answers on both the “DNA” of innovation ecosystems as well as the respective 
measures to maximize the outcome of its “innovation generation processes”.  
  
2
  A comprehensive literature review on each of these research branches is provided as a thematic basis 
within the academic articles that constitute this dissertation (see appendix). 
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2. The purpose of revisiting the NIC concept for innovation 
policy 
In summary, the national innovative capacity (NIC) concept has evolved toward 
a conceptual framework to NIS theory that feeds the concrete practice of 
improving innovation policy based on political, economic and social objectives 
(Edquist, 2009; Seliger, 2014). Policy measures are predominantly initiated on a 
national scale (Acs et al., 2016) and further research in this field should aim for 
the advancement of mostly linear national innovation policies toward becoming 
more holistic instruments of state intervention (Edquist, 2016). Therefore, sub-
national perspectives must be transformed into institutional arrangements that 
reflect and aggregate the parameters of a smoothly working innovation system – 
from the bottom (local level) to the top (supra-/national level).  
In aiming for this goal, policy makers need to know about the determinants of 
NIC and their interdependencies in terms of levels. Such lessons on the decisive 
factors of innovational outcome should enable the persons in charge of 
innovation strategy to learn and benefit from the winning formulas and mistaken 
paths of other countries.  
To this end, a thorough insight into the basic theory of NIS and its emergence 
and development is necessary to recognize the NIC framework as an explorative 
learning instrument of NIS research, with its results that transfer descriptive 
theory to legislative practice. About 450 papers and studies constitute the body of 
the most seminal academic and practical works in this field of research. 
Considering them within a big picture that consists of these studies’ research 
questions, research designs, variables and data sets as well as statistical methods 
and results of analysis leads to a holistic configurational view on NIS/NIC 
research. This approach of interpreting the current state of research has led to the 
revisiting of the concept of NIC in three respects in support of drawing the right 
conclusions for future innovation policy design: 
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 First, focus of analysis: using a comparative approach (path analysis) instead 
of a regression model to both appropriately consider the particular strengths 
and weaknesses of countries and identify the different approaches pursued by 
the countries that lead to the same outcome; 
 Second, unit of analysis: transferring the ICF to sub-national entities, such as 
industrial sectors and cities, as they “are becoming, or have already become, 
more important than the nation-state” (Freeman, 1998, p. 3; Lundvall, 2007); 
 Third, parameters of analysis: improving the complexity, choice, and source of 
the model's indicators, since innovation systems are complex phenomena and 
assessing all relevant determinants is nearly impossible (Balzat and Hanusch, 
2004). Each model is a strong simplification of the underlying innovation 
ecosystem, and assuming a “one-fits-all” set of parameters across aggregation 
levels inevitably reduces the explanatory power of the entire analysis.  
This dissertation not only contributes novel knowledge on increasing the NIC 
owing to a better understanding of the determinants of NIC, including the sub-
systems perspective. It also proposes a new approach to NIS research that bridges 
the gap between the macro (NIS) and meso levels (sectoral and local innovation 
systems), which builds the foundation for the future implementation of a fully-
fledged coordination process in countries that allows for the dynamic 
reconfiguration of NIS (Kaiser and Prange, 2004) from the bottom to the top. 
Such a process has an optimal effect at the interface between countries’ research 
and technological development policy and industrial policy, which is commonly 
regarded as “innovation policy”. National innovation policy aims to create a 
framework conducive to employment, competitiveness, environment, industry 
and energy. Against this background, the cognitions of this dissertation might be 
particularly helpful for the allocation of governmental investments to levers of 
growth and also for setting focal points within reform agendas. This study 
contributes the required indicators for comprehensive innovation scoreboards, 
pinpoints needs for structural adjustments, and notes obstacles to a high 
innovative capacity in countries.  
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3. The scientific contribution of this doctoral thesis 
This dissertation consists of three articles on the mentioned approach of 
revisiting the NIC concept. An overview of the articles with regard to authorship, 
contribution and publication status is provided in Table 1. The first article 
follows up on Furman (2002) and proposes an alternative model of innovative 
capacity research on the national level. The second article picks up threads and 
transfers the methodology to a sectoral innovation system, namely the healthcare 
sector. With the new model as basis, the third article scrutinizes the determinants 
of cities’ innovation ecosystems as “the fonts of economic innovation”
(Shearmur, 2012, 9)  
 Article 1 Article 2 Article 3 
Title Increasing the national 
innovative capacity: 
Identifying the pathways to 




Clustering the OECD 
countries by innovative 
output in healthcare using 
a multi indicator approach 
Increasing the innovative 
capacity of European 
cities: Making use of 




Dorian Proksch  
Andreas Pinkwart  
 
Dorian Proksch  
Julia Busch-Casler 






Global Innovation and 
Knowledge Academy 
(GIKA) Conference 2016; 
Valencia, Spain  











Nominated for the 
Knut Holt Best Paper 
Award 
(ISPIM 2017 Forum) 





advancements and societal 
challenges' on 
Technological Forecasting 
and Social Change 




Published in Technological 
Forecasting & Social 
Change 116 (2017) 256–
270  
(VHB Ranking in 2015: B) 
Currently under review at 
Research Policy 
(VHB Ranking in 2015: 
A). 
Final version to be 
published in Albach, H. 
et.al. (Eds.): European 





Table 1: Summary of contributions, publications and co-authors of different chapters 
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3.1 Article 1: Increasing the national innovative capacity: Identifying the pathways 
to success using a comparative method 
 Study significance: NIC is an important driver for the long-term economic 
growth and increasing the innovative capacity is a goal of many nations. Thus, 
a comparison between countries might uncover the different determinants of 
national innovative capacity. The resulting knowledge provides new insights 
for policy makers and helps them to understand the complexity of NIS. In 
contrast to the rich body of literature dealing with country comparisons against 
the background of innovative performance rankings, the actual determinants of 
innovative capacity have received only limited research attention. The few 
existing studies on this topic point out some rather unstructured determinants 
for a high capacity, but do not analyze their interconnections, let alone propose 
comprehensive strategies to increase innovative capacity. Hence, this article 
provides solid recommendations for achieving improvement on a country 
level. Moreover, this study is among the first in this research stream to apply a 
comparative method, thereby overcoming several limitations that characterize 
the majority of other studies in this field. 
 Methodological approach: We focus on the European Union (EU), since only 
a few studies have used a European data set. We collected data for 17 EU 
member states and constructed a set of 19 variables for the years 2007 to 2011. 
While data are sufficiently available for most EU countries, Bulgaria, Estonia, 
Greece, Croatia, Cyprus, Latvia, Lithuania, Luxembourg, Malta, Slovenia, and 
Slovakia had to be omitted. We build upon the ICF developed by Furman et al. 
(2002) and improve the former model in several respects (overcoming 
linearity, improving data choice as well as data complexity, erasing 
imbalances within the construct), by creating different fuzzy set Qualitative 
Comparative Analysis (fsQCA) models to test the determinants of national 
innovative capacity for the whole timespan. Boolean algebra and fuzzy set 
theory are used to do derive causal recipes for a specific outcome.  
 Main findings: We identified different paths leading to a high innovative 
capacity by combining various determinants. For instance, one set of solutions 
for high innovative output emphasizes the availability of a high capital base 
8 
(measured by GDP, a high share of government expenditure on education, the 
amount of venture capital and the general capital stock of a country). Another 
set of solutions highlights the combination of specialization in the high-tech 
industry and private funding. We were able to show each country’s 
correspondence to either entire or partial success pathways. For example, the 
UK is strong in all areas except high-tech specialization. The overall 
knowledge facilitates learning and benefitting from each other. 
 Scientific/practical value: Analysis of holistic strategies is preferable to 
focusing on single determinants. Different strategies can produce the same 
outcome. Countries can select a strategy that is based on a strength they 
already have. The ICF of Furman et al. (2002) was confirmed. In addition, 
results shed light on the role of single determinants, such as venture capital, 
high expenditure on education and high-tech specialization. Using fsQCA 
enabled us to create a robust model with a rather small data set. As multiple 
complex antecedent paths with high sufficiency exist, a linear model would 
have led to information loss. 
 Areas of improvement: Even though the data availability for EU member 
states is comparably high, 11 EU member states could not be included in this 
study owing to lack of data in the 5-year time slice. Thus a replication of this 
analysis including these 11 countries might be interesting. Further, currently 
no solution exists for working with panel data sets, even though the results 
indicate that fsQCA might also be applicable to panel data. This possibility 
needs intensive study and an empirical comparison of panel regression and 
fsQCA with multiple data sets. Another disadvantage of fsQCA that needs 
further discussion is the highly important but difficult assignment of threshold 
values (data calibration). 
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3.2 Article 2: National Health Innovation Systems: Clustering the OECD countries 
by innovative output in healthcare using a multi-indicator approach 
 Study significance: Sectoral innovation systems are an emerging field of 
research that complements the concepts of national, regional and technological 
innovation systems. Despite the high importance of innovation in healthcare 
for high-quality, cost-effective healthcare provision and, moreover, its 
prominent role as predominant field of global competition for innovativeness, 
innovation in healthcare has rarely been considered from a systems 
perspective. Few studies have examined the innovative output in healthcare 
innovation systems in the last decade, and literature on the determinants of this 
output is especially rare. This article provides a first comparison between 
countries, which facilitates revealing the relevant determinants that may 
increase the innovative output of the healthcare sub-system in future 
comparative analysis. In line with the overarching aim of increasing the 
national innovative capacity, a country comparison will allow for identifying 
the leading group of countries in healthcare innovation and thus enable policy 
makers to benchmark their own national health innovation system and draw 
lessons from the top-performing countries.  
 Methodological approach: Few investigations have used quantitative data to 
perform a comprehensive country comparison on a sectoral level, especially in 
healthcare. We performed a cluster analysis for 30 of 35 OECD nations (not 
included: Estonia, Iceland, Latvia, Luxembourg and Slovenia, owing to a lack 
of data in one or more of the output variables). As bases, we collected data for 
35 OECD member states, constructing a set of 14 variables for each country, 
covering a period of twenty years (1995–2014). The analysis is based on data 
acquired for 2012, as it is the latest year with all variables available for the 
majority of OECD countries. Although cluster analysis is a common method 
in the area of national innovation systems and healthcare systems, our study is 
one of the first to use cluster analysis to group countries by their innovation 
output in healthcare.  
 Main findings: The results show a four-cluster solution, with clusters 
comprising Scandinavian countries, the Netherlands and Switzerland showing 
10 
highest innovation output (in terms of knowledge creation and knowledge 
commercialization). The clusters differ strongly in their innovative output in 
healthcare. Cluster D is the leading cluster in three out of four variables 
(scientific papers, value added GDP and average trade balance), and ranks 
third in patents. Cluster C ranks first in patents and second in all other 
variables. Cluster A performs worst in patents and third in all other variables. 
Cluster B has the worst performance in three out of four variables but 
performs second in patents.  
 Scientific/practical value: Research adds to the current work of both national 
and sectoral innovation systems as well as innovation in healthcare. We show 
that innovation output in healthcare differs between countries and that 
countries can be grouped by this output. In this regard, we discussed potential 
reasons for those output differences, thereby providing first benchmarking 
insights for policy makers. Moreover, we have been able to confirm for the 
healthcare sector that using a multi-indicator approach provides a more 
comprehensive view on the innovative output compared to only considering 
patents as the most common proxy.  
 Areas of improvement: Performing a time series analysis on an extended data 
set consisting of further countries (OECD and non-OECD) would pay tribute 
to the dynamic and multifaceted nature of innovation systems. In addition, the 
factors chosen to measure the healthcare innovational output may not 
encompass all kinds of innovation, since process innovations are hard to 
measure and some healthcare innovations may not be patentable or cannot be 
commercialized easily. In this sense, the chosen descriptive variables may not 
encompass all relevant aspects, since healthcare systems are complex and use 
diverse indicators and systems definitions.  
  
11 
3.3 Article 3: Increasing the innovative capacity of European cities: Making use of 
proven concepts from the national level 
 Study significance: The highest rates of visible innovation occur in and around 
cities. Almost all patents and other measures of new products and processes in 
business are produced in cities. As nations’ innovation hubs, cities are the 
engines of a knowledge-based economy, shaping technological change and 
economic growth as well as the development of countries. Surprisingly, cities 
as units of analysis are fairly under-researched from an innovative capacity 
perspective. A nascent body of academic literature deals with the key elements 
of innovation in European cities. However, none of these studies draws a 
holistic picture of the determinants of cities’ innovation ecosystems. Thus, 
significant research opportunities emerge from efforts to form a consolidated 
view of European cities’ or city environments’ fragmented characteristics that 
might foster innovative capacity. Hence, this article proposes a set of variables 
reflecting European cities’ innovation ecosystems and contributes to literature 
in two ways: first, it sets the scene for respective quantitative analyses, and 
second, it closes the gap between national and local innovation systems. 
Policymakers benefit from this research as it aims for the advancement of 
mostly linear national innovation policies toward becoming more holistic 
instruments of city-specific state intervention. 
 Methodological approach: Current literature includes few empirical studies on 
innovation processes of European cities based on indicators adapted from 
other cities and regions. In keeping with these approaches, the proposition of 
this article is that proven concepts on innovative capacity from the national 
level are also applicable to cities. In the first article of this dissertation, we 
introduced an innovative comparative methodology to identify the pathways to 
success for 17 European countries. This article builds the foundation for 
transferring that framework to European cities. In the course of this, not only 
the academic work of the past 20 years is scrutinized, including the 
determinants of innovative capacity of 28 (secondary) capital cities located in 
the Czech Republic, Denmark, Estonia, Finland, France, Germany, Italy, 
12 
Netherlands, Poland, Sweden, Switzerland and UK, but also several practical 
studies in this field. 
 Main findings: The results of the investigation of appropriate parameters 
supposed to reflect European cities’ innovation ecosystems indicate differing 
innovation trajectories for different city types and their preconditions. This 
observation and the knowledge of 43 relevant city parameters, such as the 
numbers of new businesses and foreign-born inhabitants or the amount of 
foreign direct investments, have led to the conclusion that the framework 
proposed in the first article of this dissertation is transferable to city cases. 
Taking the proposed 43 parameters as a starting point, further quantitative 
research is necessary to determine the pathways leading to a high innovative 
capacity in cities. Useful for both policymakers and all involved actors, these 
pathways will be critical to successfully transforming the parameters of (all) 
local innovation ecosystems within a country into institutional arrangements 
on the upper levels. 
 Scientific/practical value: As drivers of innovation in the 21st century, 
contextual factors of innovative capacity are focal points for urban planning 
and development. Understanding the factors that shape the processes of 
innovation in cities is helpful in determining the extent to which problems 
related to city growth may be resolved. 
 Areas of improvement: The proposed 43 parameters of cities’ innovation 
ecosystems have not yet been tested for their influence on a suitable outcome 
variable, such as patents. Moreover, not all facets of innovation in cities can be 
reflected and measured by variables. In this sense, all the issues adhering to 
patent statistics as measures of innovative capacity have to be considered. 
Another major challenge for future quantitative research in this field will be 
finding appropriate data sources.   
13 
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Abstract:  
The importance of innovation in healthcare has increased within the last decades as new 
challenges like risings costs and an aging demographic have to be solved. The degree of 
innovativeness in healthcare is strongly influenced by the National Health Innovation System, 
which encompasses a wide variety of actors and related knowledge. Despite the highly 
practical relevance of the topic, there are only a few studies that analyze innovation in 
healthcare on a national level. Thus, this study is a starting point and answers the following 
questions building on the theoretical framework of national innovation systems: “Can 
countries be grouped by their innovation output in healthcare and do those groups differ in 
factors describing the healthcare system?” We compare the healthcare innovation output of 30 
OECD countries using a multi-indicator approach and categorize them into four distinct 
groups using cluster analysis. The cluster consisting of the Scandinavian countries, the 
Netherlands and Switzerland shows the highest innovation output measured in knowledge and 
commercial output. Policy makers and researchers might be particularly interested in studying 
the healthcare systems of these countries. 
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The healthcare system faces the constant challenge of adapting to the newest technology and 
to changing demands from payers and patients. Thus, innovation is a critical factor in the 
development and survival of organizations within the healthcare system (Goyen and Debatin, 
2009; Hartweg et al., 2015; Janssen and Moors, 2013; Lansisalmi et al., 2006; Thune and 
Mina, 2016). It is not only a relevant topic for management in healthcare organizations and 
related companies; it is also a prevalent issue for policy makers. This is especially true in light 
of increasing healthcare cost throughout the developed countries combined with an aging 
demographic and continuous technological advancement (Jones, 2002; Thune and Mina, 
2016). The relevance of healthcare innovation is for example reflected in the EU initiative 
Future and Emerging Technologies (FET). It takes on a prevalent role with topics such as, 
among others, digital health, robotics in healthcare, regenerative medicine, biosensors, and 4D 
human charting (European Commission, 2017). Additionally, contemporary research largely 
refers to the fields of NBIC (nanotechnology, biotechnology and life sciences, information 
and communication technology, cognitive sciences and neurotechnology) as predominant 
fields of global competition for innovativeness (Islam and Miyazaki, 2009; Wohlmuth, 2013). 
Healthcare happens within a very wide context of participants, their relationships, and 
their contextual knowledge. Creating and implementing innovation in this sector requires 
bridging the gaps between the actors. Thus, the topic provides significant research 
opportunities. Surprisingly, the field of innovation in healthcare is fairly under researched 
from an innovation perspective; however, the number of papers published increased slightly 
in recent years (Thune and Mina, 2016). Several authors suggest viewing innovation in 
healthcare through the context of innovation systems (Consoli and Mina, 2009; Larisch et al., 
2016; Ramlogan et al., 2007). Current research is mainly concerned with specific single 
technologies (Consoli and Mina, 2009; Consoli et al., 2016; Metcalfe, 2005; Petersen et al., 
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2016) and actors such as physicians (Chatterji et al., 2008), hospitals (Miller and French, 
2016) or patients (Oliveira et al., 2015) and rarely provides a systems viewpoint (Larisch et 
al., 2016).  
There is already a great variety of comparisons between the national innovation systems 
of different countries. However, there is currently no empirical evidence on the output of 
health innovation systems (HIS), despite the call for further research being conducted in the 
field of national and regional specifics of HIS and delivery of clinical service (Barnhoorn et 
al., 2013; Larisch et al., 2016; Schnarr et al., 2015; Thune and Mina, 2016). With innovative 
capacity as the central focus, our research contributes to revealing the relevant factors that 
may increase the innovative output of healthcare systems. This first paper sheds light on the 
innovation output of HIS on a national level to facilitate a first comparison between countries. 
Empirical comparisons in innovation capacity literature covering sector specific cases are rare 
so far (Klein and Sauer, 2016; Schrempf et al., 2013). Thus, our work provides an empirical 
basis for further research into the factors affecting sectoral innovation output and answers the 
following questions: “Can countries be grouped by their innovation output in healthcare and 
do those groups differ in factors describing the healthcare system?” Additionally, the results 
help policy makers to benchmark their own National Health Innovation System (NHIS) and 
draw lessons from the top-performing countries.  
With this, the paper not only contributes to closing the gap between national and sectoral 
innovation systems in literature, but also to transforming mostly linear (national) innovation 




2. Theoretical Background 
2.1 From National to Sectoral Innovation System 
The research on national innovation systems (NIS) traces back to the nineteenth century, 
when Friedrich List published his main works on economics. List’s conviction was that a 
combination of social and political factors determines the development of an economy. He 
suggested several recommendations on public policy in order to spur Germany’s 
industrialization and economic growth so it could catch up with England, a highly 
industrialized and leading economy at the time (List and Colwell, 1856).  
Roughly 100 years later, Robert Merton Solow followed up on List’s thinking within a 
wider economic context: exogenous growth theory (Solow, 1956). Broadly speaking, he 
considers technical progress as external force which primarily drives economic growth. 
However, this technical progress remains somehow unexplained. Therefore, a group of 
economists advanced Solow’s thoughts towards endogenous growth theory, which 
encompasses all key determinants of economic growth. Besides investment in human capital 
and knowledge, investment in innovation is defined as a significant success factor of 
economic growth (Romer, 1986, 1990). In particular, policy measures, such as setting 
incentives for innovation in healthcare, are designated as the determinants of the long run 
growth rate of an economy (Romer, 1990). From Romer on, research on innovative capacity 
and innovation policy has made great progress and provides a rich field of studies (Sun and 
Grimes, 2016).  
Within the last six decades, scholars from all over the world formed a body of NIS 
literature, combining elements of growth theory and the Schumpeterian school of thought 
(Schumpeter, 1939) with modern, systemic approaches to innovation (Balzat and Hanusch, 
2004). This body of literature consists of several streams which build the foundation of 
current NIS research. For our reflections on National Health Innovation Systems (NHIS) we 
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stick to these macroeconomic perspectives and add a microeconomic layer (healthcare sector). 
In summary the logic of our research is structured alongside the following aspects: 
1. Economic theory (Freeman, 1989; Freeman, 2001, 2002; Porter, 1998; Romer, 1986, 
1990);  
2. An explanation of the need for  
a. interaction between the government, science and its actors, industries, clusters 
and (entrepreneurial) firms, financial institutions (Johnson et al., 2003; 
Lundvall, 2007; Lundvall, 1998; Lundvall, 2010; Lundvall et al., 2002),  
b. technological change (Bergek et al., 2008; Carlsson and Stankiewicz, 1991); 
3. A systemic approach aiming for the translation of NIS “from a conceptual framework 
to theory that feeds a concrete practice” (Edquist, 2001, 2009, 2013, 2013, 2016); 
4. Innovative capacity measurement (Furman et al., 2002; Porter and Stern, 2000; Porter 
and Stern, 2001, 2004); 
5. The advancement and transfer of the NIS concept towards global (Potts, 2016), 
regional (Acs, 2000; Acs et al., 2002; Acs et al., 2016, 2016; Cooke, 1992, 2002; 
Cooke et al., 1997; Yoon et al., 2015) and sectoral application cases (Malerba, 2002); 
6. The healthcare innovation system (a detailed overview of the most seminal research 
on this field is presented below); 
7. Country comparisons (Nelson, 1992, 1993).  
Based on this taxonomy the following deductive definition of national innovation systems is 
considered as the conceptual basis of our analysis: 
The term NIS consists of a political and governmental unit (“nation”) and new or better 
goods/services as well as new ways of producing them – so called product and process 
“innovation” (Edquist, 2009). The term system within NIS determines the innovation process 
and refers to a set of institutions whose interactions determine the innovative performance of 
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national firms. In addition, the systems of innovation approach is clustered along geographical 
and political aspects into three different dimensions, in literature broadly discussed as 
regional, sectoral, and national innovation systems (Acs et al., 2016, p. 8). 
Naturally, the parameters of innovative capacity differ across these three levels. 
However, the national context remains most important, since it is the level “where the ‘rules 
of the game’ [national policies] are fixed” (Acs et al., 2016). National policies have to 
transform sectoral perspectives into institutional arrangements that reflect and aggregate the 
parameters of a well working innovation system. Institutional changes, changes in economic 
incentives and the setting of new quantified targets are only a few of the parameters that have 
to be addressed. “But how can all relevant policy areas be perfectly matched? How can 
knowledge demand and supply be optimally organized? Which authorities, companies, and 
other institutions need to cooperate, and how can they be optimally orchestrated? What 
weaknesses reside within the linkage of crucial players?” (Proksch et al., 2016). These 
questions regarding the healthcare industry can be answered by analyzing the respective 
sectoral innovation (sub-) system. 
The notion of sectoral innovation systems (SIS) complements the concepts of national, 
regional and technological innovation systems. According to (Malerba, 2002) each innovation 
system has a particular focus. Whereas national and regional innovation systems regard 
geopolitical boundaries as static and given, the boundaries of a SIS are rather dynamic, as the 
“sectoral as well as the technological innovation system approaches adopt a certain 
technology (spanning multiple sectors) or the sector in which it is used (including various 
technologies) as their system boundary.” (Schrempf et al., 2013) In a broader sense, the 
following definition can be considered for all SIS and, in a second step, narrowed down to the 
particularities of the healthcare sector. 
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“A sectoral system is a set of products and the set of agents carrying out market and non-
market interactions for the creation, production and sale of those products. A sectoral system 
has a specific knowledge base, technologies, inputs and demand. Agents are individuals and 
organizations at various levels of aggregation. They interact through processes of 
communication, exchange, co-operation, competition and command, and these interactions 
are shaped by institutions.” (Malerba, 2002) 
In current literature, the SIS approach is rather underdeveloped and of limited impact 
within the systems of innovation research stream. Consequently, HISs have not been covered 
in-depth either, which is quite surprising, as healthcare plays an important role in all countries 
(which e.g. is also reflected in the large share of pharmaceutical products at the worldwide 
high-tech exports). However, slowly but surely research on this particular field gathers 
momentum and first attempts to explain and examine HISs can be found. True to the 
“morphological” nature of innovation studies as such, these scientific contributions do not 
rigorously stick to (Malerba’s) theories about SIS, as presented in the next chapter. 
2.2 National Health Innovation Systems 
The term health innovation system was coined by (Ramlogan et al., 2007), who link the 
healthcare system with existing literature on innovation systems, taking SIS innovation 
literature into account. They state that the healthcare system encompasses a wide variety of 
actors (payers, practitioners, providers, patients, researchers etc.) and related knowledge. The 
knowledge needs to be coordinated in an efficient manner to provide patients with adequate 
care levels and thus help develop, diffuse and utilize innovation. This constitutes a sectoral 
innovation system according to the definition of (Malerba, 2002). Following a network 
analysis approach for glaucoma and cardiovascular disease, (Mina et al., 2007) and 
(Ramlogan et al., 2007), however, argue, that there is a multitude of “medical micro 
innovation systems” (Mina et al., 2007). Each of these is linked to specific medical research 
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and spreads across geopolitical boundaries. This definition takes parts of Malerba’s definition 
into account, but breaks it down to a much smaller level of sectoral innovation. (Consoli and 
Mina, 2009) categorize HIS into a “science and technology system” and a “health delivery 
system”. Both “subsystems” are linked by redistributed knowledge across the specializations 
(researchers, physicians, etc.) working in the respective systems. This connection enables the 
spread and further development of knowledge and thus, innovation, through gateways (the 
actors within the institutions) and pathways (trajectories towards innovation), that may be 
independent of geopolitical boundaries. (Weigel, 2011) takes another approach and analyzes a 
very narrow regional health innovation system in the Bern region in Switzerland, closely 
looking at the role of specific actors in the region. (Larisch et al., 2016) focus on a regional 
health innovation system evolving around the city of Stockholm, which encompasses all 
institutions and healthcare fields in the region. They further mention in a side note that this 
small regional system is part of the national health innovation system of Sweden. (Lawton 
Smith et al., 2016) state in that regard: “Within those two [national and regional innovation 
systems] are sectoral systems, which describe the sectoral specifics of non-linear paths from 
research to commercialization (value chain) within the local geographic context (micro 
geographies), which are sustained by the macro (country) and meso (region/state) but also 
sustain the macro and the meso through feedback loops for sustainable policy development.”.  
There is a link between those innovation systems (see also (Asheim and Coenen, 2005; 
Pombo-Juárez et al., 2016), whereby the sectoral HIS is influenced by the regional and 
national specifics related to HISs. Thus, health innovation is linked to healthcare systems 
(Battista et al., 1994; Metcalfe, 2005), especially since innovation diffusion from bench to 
bedside is often dependent on prevalent conditions for e.g. reimbursement and financing in 




Considering the previous research, measuring the innovation output of a NHIS could 
provide valuable insights in terms of cross-country benchmarking and the development of 
policy recommendations. However, none of the previous papers provides empirical evidence 
on the actual innovation output of such a HIS on a national level. Thus, grouping countries by 
their innovation output in healthcare and discussing differences among those groups is an 





3.1 Data collection 
We collected data for 35 OECD member states, constructing a set of 14 variables for each 
country, covering a period of nine years (1997 to 2015). We used the following public 
databases: OECD Statistics, US National Center for Science and Engineering Statistics, 
Scimago Journal & Country Rank, World Intellectual Property Organization as well as the 
World Health Organization Global Health Observatory. All these databases fulfill the 
statistical requirements (data availability, consistency and reliability) necessary for our 
research. Ultimately, our analysis is based upon the data acquired for the year 2012, since this 
was the latest year with all variables available for the majority of OECD countries. Overall, 
our analysis covers 30 out of 35 OECD member states. Five OECD countries, namely 
Estonia, Iceland, Latvia, Luxembourg and Slovenia, had to be omitted from the analysis due 
to a lack of data in one or more of the output variables. This is in line with previous research 
on OECD countries in the field of healthcare that also suffer from a lack of data availability 
for some variables and countries (Baltagi et al., 2012; Bohm et al., 2013). An overview of the 
variables and respective data sources can be found in Appendix A (description of variables) 
and Appendix B (descriptive statistics on variables).1 
3.2 Variables 
3.2.1. Innovative output variables 
While older studies solely focus on the number of patents per year to measure national 
innovation output (Furman and Hayes, 2004; Furman et al., 2002), scholars argue that not 
only knowledge production but also commercialization is important for the innovation output 
(Guan and Chen, 2012; Moon and Lee, 2005). Therefore, we followed the framework of 
                                                     
1 Detailed information and spreadsheets can be requested from the authors. 
11 
 
(Moon and Lee, 2005)2 and adapted it to HIS. Consequently, we quantify the innovative 
output in healthcare through the following pairs of variables per construct: 
Knowledge production: 
• Total number of patent applications under the category healthcare per 1 million 
population (WIPO Statistics Database, 2016);   
• Number of scientific papers per 1 million population (SCImago, 2015). 
Knowledge commercialization: 
• Value add in healthcare and pharmaceutical industries as percentage of the GDP 
(National Science Foundation, 2016); 
• Trade balance of the pharmaceutical industries in percentage of GDP (OECD, 2016d).  
As current literature does not offer empirical evidence on the innovative output of health 
innovation systems, there are no similar constructs that could have been taken into account as 
alternative configurations to measure innovative output in healthcare. In general, the aim of 
assembling the right set of innovative output variables is capturing a maximum of all 
innovation produced in a certain context and, while doing so, erasing dissimilarities like 
differences in local law (Adam, 2014; Carlsson et al., 2002; Schmoch et al., 2006). The 
proposed construct used in our analysis complies with this demand and is in line with OECD 
standards for collecting and interpreting innovation data (OECD, 2001, 2005, 2016c). The 
OECD also provides a consistent taxonomy for healthcare related products and services, 
consisting of the subsets health and pharma (Hatzichronoglou, 1997; Serve, 2015). We 
rigorously applied this definition cross databases and only had to cope with minimal 
divergences, which can be neglected, as they were insignificant.  
                                                     
2 Moon and Lee propose a composite indicator intending to measure innovative performance on national level. 
The configuration of this indicator is based on the weighted results of 111 expert interviews carried out in 
industry (16.2%), academic fields (48.7%; thereof 81.1% natural science or engineering and 18.9% social 
science) and public institutes (35.1%).  
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3.2.3. Healthcare systems variables 
In order to characterize the healthcare systems underlying the national health innovation 
output, we look at a set of variables commonly used to describe the healthcare system of a 
country (Anderson and Hussey, 2001; Baltagi et al., 2012; Battista et al., 1994; Delgado, 
2016; Docteur and Oxley, 2003). These include: 
• healthcare spending (WHO, 2016); 
• doctors and hospital beds (OECD, 2014b, 2015c); 
• healthcare personnel per bed (OECD, 2016b); 
• percentage of the workforce employed in the hospital sector (OECD, 2014c); 
• CT and MRI units (OECD, 2015b, 2015d);  
• patients consultations with doctors (OECD, 2015a);  
• length of the hospital stay (OECD, 2016a);  
• number of elderly people (>65) (OECD, 2014a). 
Studying OECD countries provides researchers with certain homogeneity when considering 
factors regarding public health such as life expectancy or mortality (Anderson and Hussey, 
2001). Thus, indicators commonly used to describe the general health of the population, such 
as life expectancy, neonatal mortality, mortality, level of alcohol consumption or level of 
immunization (see (Anderson and Hussey, 2001; Globerman, S., Hodges, H., & Vining, A., 
2001), are excluded from the analysis. We further excluded qualitative indicators on 
healthcare systems, as there is currently only limited literature that allows for a 
comprehensive system comparison among OECD countries (e.g. (Bohm et al., 2013; Wendt et 
al., 2009).  
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3.3 Cluster analysis 
We used cluster analysis to assess if the OECD countries can be grouped by the innovative 
output in healthcare. Cluster analysis is a common method in the area of national innovation 
systems (Gomez et al., 2014; Hollenstein, 2003; Nasierowski and Arcelus, 2003; Samara et 
al., 2012) and health care systems (Bohm et al., 2013; Borisova, 2011; Wendt, 2009). 
However, it has not been applied to NHIS for so far.  
The goal of cluster analysis is to categorize a number of observations into a restricted 
number of homogenous clusters. The distance among the clusters should be maximized and 
the distance between the members of a cluster should be minimized (Hair et al., 2014). 
We applied a hierarchical cluster analysis technique using Ward’s method with squared 
Euclidean distances (Hair et al., 2014). We used the four previously described national health 
innovation output variables as cluster variables. The results showed a two to nine cluster 
solution. We then evaluated the different solutions. Ultimately, the four-cluster solution 
showed the most interpretable results. The smallest cluster should at least include 10% of all 
cases (Hair et al., 2014). A five-cluster classification would result in a cluster with less than 
10% of the cases and therefore lead to a result that is difficult to interpret.  
To assess the statistical validity of our cluster approach, we applied discriminant analysis. 
We tested if a set of functions existed that could segment the data set within the respective 
clusters based on the health innovation outcome variables, thereby following the approach of 
(Hill and Brennan, 2000). As Table 1 shows, the first discriminant function is significant, the 
second and third are not. However, the first function explains 96.9% of the variance and is 
therefore by itself sufficient to create a valid classification. The discriminant functions 
achieved a classification accuracy of 100 %. Therefore, the maximum chance criterion and the 
proportional chance criterion are fulfilled. The discriminant analysis showed that the health 
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innovation output variables can be used to segment the four clusters. This means that our 













1 12.321 96.9 0.962 0.054 72.983 0.000 
2 0.378 3.0 0.528 0.719 8.249 0.220 
3 0.02 0.0 0.050 0.998 0.062 0.970 





Our clustering approach has led to four clusters. Table 2 shows which countries are 
categorized within which cluster. Cluster A encompasses many of the Central, Western and 
Southern European countries (Germany, France, Italy, Spain, Portugal, the Czech Republic 
and Greece). Cluster B consists of the South American (Chile, Mexico), Asian (Japan, South 
Korea) and Eastern European countries (Hungary, Poland, Slovak Republic) as well as 
Turkey. Cluster C encompasses the United States, Canada, Australia, New Zealand, the 
United Kingdom, Austria, Ireland, Belgium, Finland and Israel. It is also the largest cluster 
with 10 member countries. Cluster D includes the Scandinavian countries (excluding 
Finland), the Netherlands as well as Switzerland, making up the smallest of the clusters. The 
clusters are not only based on the health innovation output but also show a slight regional 
focus. This regional focus can also be seen in Figure 1. 



































Fig. 1. Countries according to their cluster affiliation 
The average innovation health output of the clusters is shown in Table 3. Cluster A has the 
weakest output in patents and the second weakest output in papers. It is ranked third in the 
areas of valued added and trade balance. Cluster B ranks second in patent output and last in 
all three other areas, thus being the least innovative cluster in this analysis. Cluster C ranks 
first in patent output and second in the three other areas. Cluster D ranks first in all areas 
except of patent output. It is thus classified as the most innovative cluster in our analysis. In 
patent output, however, it only ranks third. We can therefore state that the clusters strongly 










Value 8.76 48.07 122.65 15.49 






Value 626.18 267.12 1,087.78 1,728.82 





Value 6% 3% 8% 13% 







Value 0.49% 0.38% 1.87% 2.54 % 
Rank 3 4 2 1 
Table 3 - Average innovation health output per cluster 
We further tested if the clusters differ in central health related variables using One-Way 
ANOVA. Table 4 shows that this is the case for healthcare spending, elderly population, 
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doctors per million, doctor’s visits, percentage of the workforce in healthcare and healthcare 
personnel per bed. 
Variable df F-value Significance 
HPatents 29 2.660 0.069* 
HPapers 29 88.621 0.000*** 
HValueAdd 29 24.977 0.000*** 
HHigh-Tech Export 29 1.190 0.333 
HSpending 29 5.720 0.004*** 
Elderly Population 28 3.747 0.024** 
Doctors per 1000 25 7.318 0.001*** 
Beds per 1000 27 1.162 0.345 
CT per Million 23 0.794 0.511 
MRI per Million 21 1.228 0.329 
Doctor’s Visits 21 2.501 0.092* 
Length Hospital Stay 25 1.093 0.373 
Percent Workforce in HC 29 19.383 0.000*** 
HC Persons per Bed 19 4.422 0.019** 
Table 4 - Results of the ANOVA  
(* significant on 90% level, ** significant on 95% level, *** significant on 99% level) 
Table 5 shows the averages for the variables describing the healthcare system by cluster. 
Clusters C and D have higher healthcare spending than the other clusters. The highest 
numbers of elderly people (over the age of 65) exist in cluster A and D. Both of those clusters 
also have the highest number of doctors. The annual doctor visits per patient are much higher 
in cluster A and B than in the other both. The length of the hospital stay is longest in cluster 
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B. The highest amount of workforce is employed in cluster D, followed by cluster C. Also, 
both clusters have the highest amount of healthcare personnel per bed. 
 Cluster A Cluster B Cluster C Cluster D 
HSpending 9.7% 7.3% 10.5% 10.9% 
Elderly 
Population 
18.91% 12.91% 14.92% 17.81% 
Doctors per 
1000 
3.67 2.33 3.06 3.67 
Beds per 1000 5.09 6.20 4.00 3.80 
CT per Million 22.60 15.07 23.29 26.22 
MRI per 
Million 
16.73 7.75 14.65 11.82 
Doctor’s Visits 7.90 8.96 5.86 4.42 
Length 
Hospital Stay 




9.1 5.9 12.6 16.8 
HC Persons per 
Bed 
2.57 1.77 4.59 5.15 





Our research adds to the current work of both national and sectoral innovations systems as 
well as innovation in healthcare. Innovation output in healthcare differs between countries and 
they can be grouped by this output. Thus, it may make sense to see which cluster a country 
belongs to and then further analyze how to advance its healthcare system in order to create a 
higher innovation output in healthcare. Findings on the overall HIS may not be applicable to 
specific countries, but rather have to be interpreted within their respective cluster.  
The Scandinavian countries (excluding Finland), the Netherlands and Switzerland show 
the highest innovation output measured in terms of knowledge production and knowledge 
commercialization in healthcare among the OECD countries. This is in accordance with 
previous studies showing a high innovativeness of the healthcare system in Switzerland due to 
a strong interconnection between research and its commercialization aided by a strong 
industrial engagement, especially in the pharmaceutical sector (Lawton Smith et al., 2016; 
Marxt and Brunner, 2013). However, there is a need for further research to find out if and 
why this may also be the case for the Scandinavian countries and the Netherlands, as there is 
currently no detailed research on those countries’ NHIS. A first indicator might be that within 
this cluster the healthcare spending is the highest and the percentage of workforce employed 
in health is also the highest. Thus, actors within the NHISs in Scandinavian countries, the 
Netherlands and Switzerland may have more financial and human resources and thus a higher 
capacity to innovate. Previous studies already indicated the linkage between healthcare 
innovation and related resources (Delgado, 2016; Lawton Smith et al., 2016). Surprisingly, 
the amount of doctor visits per year is the lowest among all clusters. This may be due to the 
organization of the Scandinavian healthcare system with a focus on primary care centers and 
nurses as a first contact point (Anell, 2015). This, however, needs further explanation.  
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Countries in this cluster only ranked third regarding the number of patents in healthcare, 
which is not in line with the other indicators of national health output. An explanation might 
be that while these countries focus on the commercialization of their innovations, they do not 
file patent in their own countries but in other countries with potential bigger markets 
(Archontakis and Varsakelis, 2016). This might be especially the case as the countries within 
this cluster have a relative low population (Sweden with around 10 million has the highest 
population) and therefore a rather small regional market.  
Cluster C (encompassing Australia, New Zealand, Israel, United States, Canada, Austria, 
United Kingdom, Ireland, Belgium, Finland) has the highest patent output but ranks only 
second in all other categories. A reason for that can be that researchers and doctors are 
incentivized to protect their knowledge through patents. (Lawton Smith et al., 2016) and 
(Delgado, 2016) show similar evidence in their analyses of UK’s regional respectively 
national health innovation system. Possibly, the commercialization of these innovations is not 
fostered in the same way as in cluster D. (Peters et al, 2006) already indicate that healthcare 
systems are strongly influenced by their institutional arrangements and the social context that 
they are embedded within. In addition, the infrastructure and incentives to commercialize 
innovations might not be as strong, as indicated by (Lawton Smith et al., 2016) in the UK 
example. Another explanation may be the scope of patentable innovation in the respective 
jurisdictions. Several studies already indicated a patent gap between different countries (Fu 
and Yang, 2009; Grupp and Schmoch, 1999; Hall and Mairesse, 2006).  
Overall, the two most successful clusters have the highest healthcare spending, the 
biggest workforce employed in healthcare and the highest amount of healthcare personnel per 
bed. This leads to the proposition that the resource base and its allocation is an important 
factor for innovation. With this, they may be in a better position to deal with the challenges 
imposed by demographic change and rising cost, a statement which needs further elaboration.  
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Interestingly, Cluster D also has the highest percentage of elderly people and thus may 
have a stronger propensity to innovate in order to cope with the change. This may also lead to 
a stronger need for using the developed innovations in the markets and thus commercializing 
them. Overall, this analysis can serve as a starting point for a detailed examination of 
similarities and differences and related policy benchmarking and recommendations.  
Cluster B, consisting of the South American, Asian and Eastern European OECD 
countries as well as Turkey, showed the worst performance in innovation output. A reason for 
that might be a comparably low resource base (lowest healthcare spending, lowest amount of 
doctors per 1,000 population and lowest percentage of the population employed in 
healthcare). Combining this with a high demand for healthcare services, as indicated by the 
highest percentage of elderly population as well as the highest number of doctor visits per 
patient and the longest stays in hospitals creates a rather challenging environment. Possibly, 
all resources must be used for basic medical care and patient treatment and thus, there may be 
no more time, resources and room to innovate. This may lead to a lower efficiency in 
healthcare service provision as indicated by a long hospital stay (OECD, 2016a). Another 
explanation could lie in the nature of the policies related to innovation. (Delgado, 2016) 
describes e.g. the Japanese healthcare industry as rather “innovation-shy” and more focused 
on reverse engineering. 
Finally, Cluster A (encompassing Germany, France, Italy, Spain, Portugal, the Czech 
Republic and Greece) performs poorly regarding the innovation output. Again, there is a 
combination of the highest percentage of elderly people (18.9%) together with a 
comparatively low resource base when considering healthcare spending and percentage of 
workforce employed in the healthcare sector. However, the cluster shows a high number of 
doctors and a comparably lower number of beds and a length of hospital stays being much 
closer to the top group, indicating a higher level of efficiency (OECD, 2016a). This could 
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indicate that the focus within the healthcare system lies more in gaining efficiency through 
incremental improvements. (Delgado, 2016) suggests that due to the somewhat fragmented 
nature of the German healthcare system, there might be a disconnection between the 
healthcare system and its related policies on the one hand and the industry and research 




6. Limitations, implications and further researchers 
Limitations 
Rating the innovativeness of countries is challenging. Measuring the innovation output in 
healthcare along the previously described four factors may not encompass all innovations. 
Process innovations are especially hard to measure. Further, patents and scientific articles 
may not always lead to new products and services. Additionally, certain healthcare 
innovations (e.g. medical process innovation or innovation relating to more efficient patient 
pathways) may not be patentable depending on different jurisdictions and may be thus 
(partially) excluded from our analysis. However, we used the (Moon and Lee, 2005) indicator 
for our research and believe that the combination of its factors leads to a maximum coverage 
of innovations.  
Additionally, this research would have benefitted from one data source offering the 
required data for both the innovative output variables and also the healthcare system 
variables. This would have erased even slightest divergences in data taxonomy and 
definitions. 
Further, only 30 out of the 35 OECD countries could be included in the study due to data 
availability issues. However, the sample includes most of the economically stronger countries 
with established healthcare systems. Therefore, we believe that the sample is large enough to 
derive comprehensive conclusions, which can also serve as benchmarks for emerging health 
systems in non-OECD countries.  
The descriptive variables show the major variables characterizing healthcare systems and 
serve as a first indicator for characterizing the NHIS clusters. However, they may not 
encompass all relevant variables, especially since healthcare, related regulations and 
healthcare financing are complex systems with diverse indicators and systems definitions. We 
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believe that we can provide substantive insights into the clusters with the chosen variables, as 
we used common indicators to describe the systems. 
Implications 
This research might be of great interest for policy makers as healthcare systems are an 
important issue in political discussions. Raising the national innovation output within the 
healthcare system may lead to cost savings and better patient care. Therefore, nations can 
create policies that foster more innovation within the healthcare systems. For this, it is 
important to know which countries have a high innovation output in healthcare to derive best-
practices. This research shows that policy makers might be particularly interested in studying 
the healthcare systems of the Scandinavian countries, the Netherlands and Switzerland and 
taking them into account when considering new political reforms.  
Further research 
We showed that the Scandinavian countries, the Netherlands and Switzerland have the highest 
innovation output in healthcare among OECD countries. However, it is currently not clear 
why this seems to be the case. Possible reasons can include national policies, the national 
infrastructure and the resource base. A comprehensive analysis of determinants of the NHISs 
can lead to a better understanding of the phenomenon.  
Further, this research was performed with a limited data set. Extending the data set to all 
OECD countries as well as non-OECD countries with emerging healthcare systems such as 
China, Brazil or India (as already indicated by (Delgado, 2016) would extend the findings and 
provide further insights into NHIS. Also, a broader data set may enable researchers to include 
a time series analysis. Covering more than one year may lead to more robust results and pays 
the necessary academic tribute to the dynamics and multifaceted nature of the NHIS as subset 
of a country’s NIS. 
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Finally, extending the descriptors of the underlying healthcare system to qualitative data 
describing the healthcare systems and their governance may lead to an even more 
comprehensive picture of NHIS. Detailed case studies and case comparisons of countries 






Within this paper we discuss the innovative output in healthcare of 30 OECD countries using 
a multi indicator approach. Despite the high relevance of the topic, there are only few 
empirical studies on the NHIS. We are one of the first who use a cluster analysis to group 
countries by their innovation output in healthcare and scrutinize obvious differences based on 
the certain factors that describe the national healthcare systems. We found four distinct 
clusters, whereby the cluster comprising of Scandinavian countries, the Netherlands and 
Switzerland shows the highest innovation output measured in terms of knowledge creation 
and knowledge commercialization. We discussed potential reasons for the outcome and 
provided first benchmarking insights for policy makers. With this, we contributed to the 
scientific discourse on national as well as sectoral innovation systems research as well as the 
literature on NHIS.  
  
Appendix A: Description of variables 
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Variable Scale Full variable name Definition in our model Source Based on 
Innovative Output – Dependent Variable 
HPatents j, 2012 Number, total 




1 mn population 
Total health patent 
applications (direct 
and PCT national 
phase entries) 
Health definition used: 
Medical Technology IPC Codes 
(WIPO, 1979): A61B; A61B 8/12; 
A61B 10/04; A61B 17/00; A61B 18/22; 
A61B 3/00 [2006.01]  
Pharmaceuticals IPC Codes (WIPO, 





Moon and Lee, 2005 
HPapers j, 2012 Number, Total 
count of Health 
documents; per 
1 mn population 
Health documents Health definition used: 
Dentistry, Health Professions, Medicine, 
Neuroscience, Nursing, Pharmacology, 
Toxicology and Pharmaceutics 
Scopus® 
database 
(Moon and Lee, 2005) 




Value added of health 
and pharma industries 
Health definition used: 
Value added of pharmaceuticals 
industry, by region/country/economy; 





(Moon and Lee, 2005) 
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services, by region/country/economy.  
(Value added is the amount contributed 
by a country, firm, or other entity to the 
value of a good or service and excludes 
purchases of domestic and imported 
materials and inputs.) 
Statistics 








Health definition used: 
Pharmacy SITC Revision 3  
(Hatzichronoglou, 1997); Medical/ 
optical instruments are not included 
OECD Stats (Moon and Lee, 2005) 
Healthcare systems - independent variables 




Total expenditure on 
health as a percentage 
of gross domestic 
product 
Total expenditure on health expressed as 





Docteur & Oxley (2003), 
see also Anderson & Hussey 
(2001), Globerman et al 
(2001), Delgado (2016) 
Elderly Population j, 2012 Total percentage 
of population 
Eelderly population people aged 65 and over OECD Data Battista (1994), see also 
Arah et al (2003) 
Appendix A: Description of variables 
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Doctors Per 1000 j, 2012 Total, per 1.000 
inhabitants 
Doctors "Practicing" doctors providing direct 
care to patients (exemption: Canada, 
Finland, France, Ireland, Italy, the 
Netherlands, Slovakia and Turkey: 
"professionally active" doctors)  
OECD Data Battista (1994), see also 
Anderson & Hussey (2001), 
Globerman et al (2001), 
Delgado (2016) 
Beds Per 1000 j, 2012 Total, per 1.000 
inhabitants 
Hospital beds Number of beds that are maintained, 
staffed and immediately available for 
use (acute care beds, psychiatric care 
beds, long-term care beds and other beds 
in hospitals)  
OECD Data Battista (1994), see also 
Anderson & Hussey (2001), 
Globerman et al (2001), 
Delgado (2016) 




CT scanners OECD Data Battista (1994), see also 
Globerman et al (2001) 
MRI Per Million j, 2012 Total, per 1 mn 
population 
Magnetic resonance 
imaging (MRI) units 
MRI units  OECD Data Battista (1994), see also 
Globerman et al (2001) 
Doctor’s Visits j, 2012 Total, per capita Doctors' consultations Number of patients consultations with 
doctors (generalists and specialists) in 
various settings (e.g. hospitals) 
OECD Data Battista (1994), see also 
Anderson & Hussey (2001) 
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Length Hospital Stay j, 
2012 
Days Length of hospital stay 
(acute care) 
Average number of days that patients 
spend in hospital (excluding day cases) 
OECD Stats Battista (1994), see also 
Anderson & Hussey (2001) 





Total health and social 
employment as % of 
civilian workforce 
Human health and social 
work activities (ISIC Rev.4 – 
Section Q 851, 86, 852,87, 853, 88) 
OECD Stats Battista (1994) 
HC Person Per Bed j, 2012 Hospital-
employment-to-
bed ratio (head 
counts) 
Total hospital beds Number of beds that are maintained, 
staffed and immediately available for 
use (acute care beds, psychiatric care 
beds, long-term care beds and other beds 
in hospitals) 
OECD Stats Battista (1994) 
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Variable Min Max Med Average Std. Dev. 
Innovative Output – Dependent Variable 
HPatents j, 2012 0.72 426.49 11.43 58.33 100.36 
HScientific Papers j, 2012 43.33 2,194.49 789.90 868.07 532.33 
HValue Add j, 2012 1.10% 15.00% 7.20% 7.07% 3.93% 
HHigh-Tech Export j, 2012 0.12% 12.06% 0.44% 1.26% 2.52% 
Healthcare systems – independent variables 
HSpending j, 2012 5.24% 17.02% 9.38% 9.52% 2.27% 
Elderly Population j, 2012 6.41% 24.15% 16.60% 15.79% 4.06% 
Doctors per 1000 j, 2012 1.69 4.80 3.18 3.10 0.77 
Beds Per 1000 j, 2012 1.57 13.36 3.86 4.88 2.73 
CT per Million j, 2012 5.10 50.51 15.48 21.12 12.58 
MRI per Million j, 2012 2.17 34.43 10.35 12.80 8.98 
Doctor’s Visits j, 2012 2.90 14.30 6.75 7.03 3.46 
Length Hospital Stay j, 2012 3.90 17.50 6.15 6.73 2.43 
Percent Workforce In HC j, 2012 3.05% 21.11% 10.88% 10.70% 4.57% 
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Increasing the Innovative Capacity of European Cities:  
Making Use of Proven Concepts from the National Level 
Marcus Max Haberstroh, Andreas Pinkwart 
Abstract  
Besides facing challenges like globalization, agglomeration, digitalization, and demographical change, a 
nation finds its growth and development to be strongly influenced by its innovativeness. Innovation emanates 
from interaction and knowledge flows, and countries’ systems of innovation shape the manifold innovation 
processes. Cities are the focal point of these processes, as they serve as regional hubs that facilitate the interplay 
between all involved actors and the exchange of related knowledge. Consequently, cities as fonts of innovation 
are central to policy makers’ concerns. Despite cities’ high value as a unit of analysis, few studies have 
investigated strategies leading to a high innovative capacity in cities. However, much research has occurred at 
the national level. Among this, one study introduces an innovative methodology to identify so called pathways 
to success for European member states using a comparative method. As the national level is an aggregate of 
the lower levels, the authors assume that such proven concepts from the national level also apply to cities and 
claim that different innovation strategies with the same outcome exist, thus allowing cities to define appropriate 
policies in line with their specific preconditions. The few academic works on the determinants of innovative 
capacity of European (secondary) capital cities, as well as several practical studies in this field, provide first 
evidence of the truth of this theory. Drawing on these fragmented sources, the authors propose a consolidated 
set of 43 variables reflecting a local innovation ecosystem, thus setting the scene for a quantitative proof of the 
concept in the future. 
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Innovation has been critical for the long-term competitiveness of nations since the Industrialization Revolution 
(Romer 1986, 1990). In recent decades a scientific field has emerged, aiming to explain, forecast, and modify 
this essential of economic success (Acs et al. 2016; Atkinson 2013; Albach 2006), with elements of growth 
theory, the “Schumpeterian school of thought” (Schumpeter 1939), and modern, systemic approaches to 
innovation forming the foundation of research. This literature is dedicated to studying the production and use 
of formal and informal knowledge regarding the creation and adoption of new products and services, improved 
processes, organizational forms, and business models (Fagerberg 2016; Lundvall 2010). Regardless of whether 
the application area is country comparison, R&D forecasting, or analysis of technological systems, the doctrine 
of innovation systems is centered on the triad of innovative capacity, innovation strategy, and innovation 
policy. 
Innovative capacity makes the difference between countries’ prosperity or stagnation (Marceau 2008b; 
Furman and Hayes 2004; Porter 1990) as it reflects the level of invention and the potential for innovation in 
any nation, geographical area, or economic activity (Villa 1990; Furman et al. 2002). Studies of innovative 
capacity have focused mainly on the national level and provide a “conceptual framework to theory that feeds 
[the] concrete practice” (Edquist 2009, p. 182) of generating useful insights about the focal points of innovation 
strategy (Sun and Grimes 2016; Porter and Stern  2001, 2000, 2004). Innovation strategies build upon the 
availability, intensity, and combination of certain economic elements, such as GDP or production factors like 
capital and labor, which on the whole reflect a country’s innovation ecosystem (Edquist 2016). Together with 
organizational and institutional arrangements these elements naturally differ in terms of levels, and innovation 
policies aim to create respective regional, local and sectoral innovation areas (Couchman et al. 2008). In this 
regard, “sub-national entities, such as provinces, industrial districts, cities or ‘Silicon Valleys’ are becoming, 
or have already become, more important than the nation-state” (Freeman 1998). This importance especially 
holds true in view of the fact that the highest rates of visible innovation are found in and around cities (Athey 
et al. 2008). However, in an effort to aggregate the complexity of the various ecosystems at lower levels, 
innovation policies are largely set on the national level.  
As drivers of innovation in the 21st century, the contextual factors of innovative capacity are focal points 




cities as units of analysis are fairly under-researched from an innovative capacity perspective (Martin and 
Simmie 2008). Although research in this particular field is gathering momentum and a small body of academic 
literature deals with the key elements of innovation in European cities, no study presents a holistic picture of 
the determinants of cities’ innovation ecosystems. Thus, condensing the fragmented characteristics of 
European cities or city environments that might foster a consolidated view of innovative capacity provides 
significant research opportunities (McCann 2004). Moreover, understanding the factors that shape the 
processes of innovation in cities might also be helpful in determining the extent to which problems related to 
city growth may be resolved (Johnson 2008). Hence, this article contributes to literature in two ways, first by 
setting the scene for quantitative analyses by proposing a consolidated set of variables reflecting European 
cities’ innovation ecosystems, and second by closing the gap between national and local innovation systems. 
Policymakers also benefit from this research as it aims to advance the mostly linear national innovation policies 





2 Theoretical Foundation: About Innovation Systems and Cities 
Research on innovation systems emerged primarily from the theory of political economy. Early attempts to 
explain the development and performance of nations trace back to the forefathers of the German school of 
economics, among them especially Friedrich List. Roughly 200 years ago, he paved the way for a lively 
scientific discourse (List and Colwell 1856), in literature now recognized under the notion of exogenous 
(Solow 1956) and endogenous growth theory (Romer 1990, 1986). From Romer on, the question of the 
determinants of the long-run growth rate of an economy and in particular the contribution of innovation began 
to dominate this field of research (Acs et al. 2016).  
2.1   The Purpose of Innovation Systems Research  
Motivated by high practical relevance for policy makers, innovation scholars from all over the world are 
producing a rich body of literature consisting of various strands (Sun and Grimes 2016). At the beginning, a 
four-pronged taxonomy prevailed, with its foci on national, regional, and sectoral innovation systems and, as 
an overarching analytic perspective, the innovative capacity view, which emerged in parallel, closely attached 
to the mentioned geographies (Teixeira 2014). What today is called the innovative capacity framework was 
initially “proposed as an index that could provide regular diagnostics of national performance in invention over 
time” (Villa 1990, p. 290) with the intention to show the influence of technological change on economical 
growth.  
Meanwhile, a new plurality of studies evolved, introducing new dimensions along with new notions like 
“global,” “local” and “technical” innovation systems (Klein and Sauer 2016). Nevertheless, the methodology 
behind innovation systems research and also the research questions remains largely the same, demanding 
suitable answers on both the “DNA” of a certain country-level or industry innovation ecosystem as well as the 
respective measures to maximize the outcome of innovation endeavors (Edquist 2013, 2009, 2001).  
However, rather than merely creating innovation systems in literature, scholars try to understand them in 
order to improve them (Acs et al. 2016). In that regard, within all strands of innovation system research various 
studies propose certain strategies that might lead to high innovative capacity. Even though the determinants of 
innovative capacity differ across levels, “the ‘rules of the game’ are fixed” (Acs et al. 2016, p. 1) on the national 
level with policy measures. These measures are, for instance, institutional changes, changes in economic 




institutional arrangements that reflect and aggregate the parameters of a smoothly working innovation system 
— from the bottom (local level) to the top (supra-/national level) (Edquist 2016). To identify the right 
parameters, regional systems and the local sub-systems have to be analyzed. 
2.2      Regional Innovation Systems 
As part of a national innovation system, regional innovation systems describe the interaction of different 
sectors with regional governance, innovation support infrastructures, and the national-level system (Teixeira 
2014). In this regard, the regional innovation system concept complements the national innovation system 
concept by adding an additional layer that heavily emphasizes institutions (Parto and Doloreux 2004) and 
focuses on aspects like the proximity between firms (Klein and Sauer 2016). Even though views are 
conflicting, some scholars consider the regional level to be the “preferred spatial level for regulatory 
intervention…, rather than the central state” (Klein and Sauer 2016, p. 14). This claim is predominantly 
promoted by Philip Cooke, the widely recognized pioneer and seminal author in this strand of literature (Cooke 
1992, 2002; Cooke et al. 1997, 1998). Along with other scholars in fields of innovation, he justified the 
necessity and importance of a regional dimension within innovation systems research. Nijkamp (2016) recently 
contributed another landmark work in the context of regional innovation, presenting a novel framework 
intended to help low performers catch up. At its core, his theory builds upon regions’ unique portfolios of 
development possibilities and shows how to optimize the combination of available resources and capabilities. 
Zitek and Klimova (2016) propose a slightly different framework that highlights and builds upon knowledge 
flows within and between organizations. The study aims to identify appropriate indicators as well as a 
methodology for determining the knowledge base of a region. In line with Nijkamp’s conviction, Zitek and 
Klimova recommend considering the unique characteristics of the given region when implementing regional 
innovation policies. In summary, the strand of literature on regional innovation systems discusses a more or 
less independent and complex analytical framework generating the empirical foundation for innovation policy 
making (Parto and Doloreux 2004). In this regard, the special role of cities within regional innovation systems 
constitutes an important factor.  
Freeman, well known in the context of innovation research (Freeman 2002, 2001, 1989) , stressed the 
importance of cities within regional innovation systems based on his far-reaching studies on the root causes of 




cities for economic growth and development of countries has been done by Johnson (2008), whose research 
also tackles the question of which factors might shape the processes of innovation in cities and thereby pursues 
a systemic approach to analyze institutional, political, and technical innovation in cities. In this context he is 
among the first to apply the rarely used notion of local innovation systems. Later on, Capello et al. (2012) and 
Breschi (2001) headed in the same direction and strengthened the link between the presence of cities in the 
region and innovative performance, finding a notably high degree of innovation in regions hosting large urban 
areas and so-called dynamic agglomeration economies1 as well as knowledge spillovers generated by cities. 
The most recent contribution of Viitanen (2016) follows up on this and draws on the case of Cambridge to 
identify “the key ecosystem elements that are necessary for building up a solid foundation for the innovative 
regions” (p. 6). On the basis of these key elements he presents a holistic approach to managing the innovation 
ecosystem of the Cambridge region under the notion of the “innovation hub framework.” 
2.3      Local Innovation Systems 
As noted earlier, the local innovation systems approach is somewhat underdeveloped and of limited impact 
within the systems of the innovation research stream. The fact that the notion of local innovation systems (LIS) 
is almost never found independent from regional innovation systems (RIS) is evidence of this gap in literature.  
The LIS strand is still in its infancy. Mainly, current LIS literature is promoted by a handful of experts 
who have contributed the few fundamental works to date (Martin and Simmie 2008; Marceau 2008a, 2008b; 
Breschi 2001; Simmie 2001). However, not only academic literature addresses LIS. Large-scale international 
field studies, such as the Local Innovation Systems Project or the Regional Entrepreneurship Acceleration 
Program hosted by the Massachusetts Institute of Technology, also contribute valuable knowledge (Regional 
Entrepreneurship Acceleration Program 2017; Local Innovations Systems Project 2005). 
The notion of LIS complements the concepts of national, regional, and technological innovation systems. 
According to Martin and Simmie (2008), each innovation system has a particular focus. LIS research aims to 
increase the understanding of how localized technological innovation operates in a global economy—that is, 
the dynamics of the global–local relationship and the different ways they interconnect (Kosonen 2005). In this 
context, LIS scholars attempt to determine the conditions associated with the development of a sustainable 
                                                     




local innovation system, or the transition from one kind of system to another, as well as the role, behavior, and 
performance of local innovation systems during a period of increasing globalization (Sotarauta et al. 2004).  
In a broader sense, LISs can be defined as spatial concentrations of businesses (firms of all industries) and 
associated non-businesses (institutions like education and science, authorities, specialist associations) that 
collaborate to generate new practical knowledge, including new products or services, and to commercialize 
this knowledge (Martin and Simmie 2008). Furthermore, the LIS literature argues that “local innovation 
systems are the key driving mechanism underlying change in spatial economies because they are the primary 
source of new commercially valuable knowledge” (Martin and Simmie 2008, p. 194). 
True to the “morphological” nature of innovation studies, the notions of LIS, RIS, and sectoral innovation 
systems (SIS) are not always rigorously applied, which creates a further barrier to the emergence of a clear-
cut LIS strand in innovation systems literature.  
2.4     Cities 
Cities are comprehensive local innovation systems, “composed of the same elements as regional or national 
systems but geographically much more concentrated” (Marceau 2008b, p. 137). Cities’ innovation ecosystems 
and innovative capacity, as pivotal points within LISs, have also not been covered from academia in a 
satisfactory manner, an omission that is quite surprising since cities play an enormous economic role in 
countries’ prosperity (Kogler et al. 2016). In the EU, 271 metro regions hold 59% of the population, create 
62% of all employment, and generate 68% of GDP (European Commission 2016b). However, cities are far 
more than mere centers of population, economic activity, and employment. Almost all patents and other 
measures of new products and processes in business are produced in cities (Marceau 2008b). As nations’ 
innovation hubs, cities are the engines of a knowledge-based economy, shaping technological change and 
economic growth (Johnson 2008; Kogler et al. 2016). 
Besides elaborating on the economic role of cities and the “plain connection” between innovation and 
cities (Shearmur 2012), the vast part of current research is concerned mainly with the “smart city” and focuses 
on the entire economic role of cities. In this broader context, innovation is perceived as one of the three levers 
of cities’ competitiveness (Sáez and Periáñez 2015) and therefore a main aspect of so-called “smart economies” 
(Dameri 2017). The smart economy concept and theory are the result of knowledge-intensive and creative 




(Vinod Kumar and Dahiya 2017). In this regard, only a few studies have tested the isolated influence of single 
factors on the innovative capacity of cities. Predominantly, although not exclusively, these factors are: 
• Globalization (Eger 2012); 
• Agglomeration (Simmie 2001); 
• Urbanization (Vinod Kumar 2017; Vinod Kumar and Dahiya 2017); 
• Social dynamics of city regions and migrant and ethnic diversity (Andrew 2014);  
• Availability of "hard” production factors and non-material production factors (Caragliu et al. 2016); 
• Knowledge base of a city (Kogler et al. 2016; Zitek and Klimova 2016; Makkonen and Weidenfeld 
2016); 
• Creation, availability, and distribution of human capital (Cowling and Lee 2017; Kiuru and Inkinen 
2017); 
• Contribution of risk-loving and innovative individuals (Caragliu et al. 2016); 
• University–industry–government relations (Couchman et al. 2008); 
• Attractiveness for new businesses and investments (Sáez and Periáñez 2015); 
• Innovation platforms (Anttiroiko 2016); 
• Benefits from partnerships (Atkinson 2013); 
• Specialization patterns of inventive activities (Kogler et al. 2016); 
• Relevance of marketing systems (Briggs 2009). 
In addition, further studies attempt to test the influence of various city characteristics on the innovative 
capacity of cities in the form of so-called innovation indexes. Wang and Gong (2016), for instance, propose 
an innovation evaluation index for Shenyang, a Chinese national innovation-oriented city. Derived from the 
European innovative scoreboard and the Silicon Valley index, it is composed of three interlinked dimensions 
(innovation system, innovation input, and innovation performance), with several so-called “third-level 
indicators” underlying each dimension. Sáez and Periáñez (2015) propose another index, the urban 
competitiveness index that benchmarks the competitiveness of European cities as locations for businesses and 
in terms of their ability to attract investment. This index also consists of three dimensions not exclusively 
dedicated to innovation measurement, although one dimension focuses on an innovation construct consisting 




Besides these “academically perceptible” indexes, some rather practical indexes are to be found throughout 
the internet, such as the Regional Innovation Index calculated by the European Commission. Its aim is to help 
European cities learn from each other by comparing the performance of cities based on 12 indicators taken 
from the Regional Innovation Scoreboard (European Commission 2016a). Another example of measuring the 
impact of regional innovation policy is the Innovation Report 2009 of the German federal state of North Rhine-
Westphalia (Fertig et al. 2010). Starting from the set of indicators of innovation formerly introduced in the 
innovation reports 2006–2008, the Innovations Report 2009, in a first step, selected key indicators as subject 
for update and reinterpretation. The position of North Rhine-Westphalia was analyzed in comparison with the 
federal average as well as with the federal states of Bavaria and Baden-Wuerttemberg. The goal was to 
consolidate the whole collection of indicators into a manageable set of core indicators, for which contemporary 
data were indeed available, so that an updated summary and assessment of the genuine potential for innovation 
in North Rhine-Westphalia became possible. In so doing, North Rhine-Westphalia was engaging in an 





3 Making Use of Proven Concepts from the National Level 
However, all of these innovation evaluation indexes propose a calculation method for the innovative capacity 
of cities only. They do not provide the theoretical basis for setting the right innovation parameters within 
innovation policies. This step explaining the results on the basis of the knowledge gained from the theory of 
path dependence is rarely to be found in LIS literature. The research work done by Martin and Simmie (2008) 
tends in this direction and, in the first instance, helps in understanding the different historical economic 
trajectories followed by different cities. The authors hold that path-dependent development of new 
technologies or industrial sectors within urban economies happens in four phases, each of which depends on 
the nature and interactions of a city’s local innovation system combined with the capacity to absorb new 
knowledge.  
In keeping with the wish for understanding the factors that shape the processes of innovation in cities, we 
propose the transition of proven concepts on innovative capacity from the national level to cities, as they have 
already reached a high level of sophistication (Acs et al. 2016). 
3.1      Framework: Underpinnings of the Proposition 
Proksch et al. (2017) have proposed an innovative methodology for identifying the pathways to success for 17 
European countries using a comparative method. As a result of their analysis, those authors identified different 
paths leading to a high innovative capacity on the national level. These paths were translated into innovation 
strategies. Rather than a single strategy, different strategies with the same outcome exist, thus allowing 
countries to choose the appropriate strategies on the basis of their preconditions. The framework of Proksch et 
al. (2017) might be a good fit to city cases for the following reasons: 
• It is a novel framework that does not focus on showing the significance of single determinants on 
innovative capacity but instead analyzes the combination of different factors.  
• The framework is based on the Furman et al. (2002) model of innovative capacity and its applicability 
has been successfully proven within various innovation studies (Sun and Grimes 2016). 
• On the basis of the results (different strategies) recommendations for policy improvement can be 
expediently derived. 




studies have to cope with.2 
• It brings the advantages of fuzzy set qualitative comparative analysis (fsQCA) (Ragin 1987, 2000, 
2008) to city studies.3 
Thus, the article at hand builds the foundation for transferring the methodology used by Proksch et al. (2017) 
to European cities. For this purpose, understanding the fundamentals of the underlying Furman et al. (2002) 
model is crucial.  
According to Furman et al. (2002), the innovation ecosystem of countries can be reflected and measured 
by determinants that can be grouped into three categories: the common innovation infrastructure, the cluster-
specific environment for innovation, and the quality of their linkage. The authors hold that the interplay among 
the three categories reflects the overall innovative performance of an economy. Taking into account the so-
called Porterian Cluster (Porter 1990) and also the Idea Production Function (Porter and Stern 2000), they 
define these categories as follows (Furman et al. 2002, pp. 905–907): 
• The Common Innovation Infrastructure reflects the cumulative technological sophistication, human 
capital, and financial resources available for R&D activity, resource commitments, and policy choices 
(e.g., investments in education and training, intellectual property protection, openness to international 
trade, R&D tax policies).  
• The Cluster-Specific Environment for Innovation focuses on the microeconomic environment present 
in a nation’s industrial clusters, comprising cluster-specific circumstances, investments, and policies 
(e.g. R&D expenditures funded by industry; relative concentration of innovative output in high-tech 
patent classes).  
• The Quality of Linkage represents the relationship between the common innovation infrastructure and 
industrial clusters (e.g., R&D expenditures performed by universities, venture capital investments). 
“The strength of linkages influences the extent to which the potential for innovation induced by the 
common innovation infrastructure is translated into specific innovative outputs in a nation’s industrial 
clusters, thus shaping the realized rate of national R&D productivity” (Furman et al. 2002, p. 907).  
  
                                                     




According to Stern (2014, p. 47),  
clusters are the fulcrum around which a region [and its cities in the center of local innovation systems] realize 
the potential from its innovative and entrepreneurial capacity. Clusters shape the potential to develop and 
commercialize new technology and scale new businesses for global impact. 
In this sense, clusters and linkages allow regions and cities to focus and prioritize innovation in terms of their 
comparative advantage. Hence, on that basis the validity of this taxonomy for city cases, notwithstanding the 
fact that it was formerly introduced by Furman et al. (2002) in a national context, can be considered as given. 
The outcome of the whole construct is measured on the basis of patents as a consistent country-specific 
indicator of the level of commercially valuable innovative output. However, measuring the output of 
innovation on the basis of patent statistics has been quite controversially discussed in innovation science for 
decades (Acs et al. 2002; Griliches 1990; Pavitt 1988; Roper and Hewitt-Dundas 2015). Nevertheless, the 
suitability of patents as a valid measure of cities’ innovation outcome has been tested and confirmed. 
According to Kogler et al. (2016, p. 1), “patents provide a wealth of information to analyse the knowledge 
specialization at specific places, such as technological details and information on inventors and entities 
involved ….” The European City Report argues along similar lines, stating that “the innovative capacity of 
cities is underlined by the number of patents per inhabitant” (European Commission 2016b, p. 61). Hence, we 
rely on patents as outcome measure and thereby ensure closeness to the original model and its transferability.  
However, Proksch et al. (2017) and the original model differ regarding the Contributing and Related 
Outcome Factors. These were initially introduced to the model as “alternative output measures…that are less 
comparable across countries and likely to be less closely linked to the level of…innovative output” (Furman 
et al. 2002, pp. 912–913). In contrast to this approach, Proksch et al. (2017) consider these indicators as proxy-
determinants within a quasi-fourth category, complementing individual determinants of the other three 
categories which capture contexts that are partially difficult to measure. For instance, the economic success of 
a city can be measured by the amount of GDP, a variable that is not in itself directly relevant but that serves in 
place of this hardly graspable condition. These complementing determinants (e.g., real GDP, number of 
scientific publications, non-residential capital stock) thus become part of the modeled innovation ecosystem, 
which is a far more constructive approach than using them as sensitivity measures against the outcome variable 




data (OECD 2005).3 Transferring the entire taxonomy to city cases results in the generic model depicted in 
Figure 1.  
 
Fig. 1. Generic model: The innovative capacity framework transferred to cities (Furman et al. 2002). 
3.2      Method and Data: The Search for Appropriate Determinants 
Validating and enhancing the determinants per category from a city perspective is the critical criterion for the 
transferability of the innovative comparative methodology to identify the pathways to success. In this 
undertaking, not only the academic work of the past 20 years is scrutinized, but also several practical studies 
in this field. Table 1 depicts the in scope European (secondary) capital cities and the respective academic 
articles which, at least to a certain extent, deal with the determinants of innovative capacity.4 
  
                                                     
3 The applicability of the Oslo Manual is not limited to OECD member states, as it was jointly developed with Eurostats. 
4 The scoping constraint was whether at least some studies on the respective city’s innovation ecosystem were available, 




Country City/Region Articles 
Czech Rep. Various  Zitek and Klimova (2016) 
Denmark Copenhagen Makkonen and Weidenfeld (2016) 
 
Makkonen and Weidenfeld (2016) Estonia Tallinn 
Finland Helsinki Anttiroiko (2016); Makkonen and Weidenfeld (2016) 
Oulo Anttiroiko (2016) 
 
Anttiroiko (2016) Tampere 
France Grenoble Kogler et al. (2016) 
 
Kogler et al. (2016) Marseille 
Paris Pin and Galimberti (2016); Kogler et al. (2016); Simmie (2001) 
Toulouse Kogler et al. (2016) 
Germany Dortmund Athey et al. (2008) 
Stuttgart Simmie (2001) 
Italy Genoa Dameri (2017) 
Milan Pin and Galimberti (2016); Simmie (2001) 
Netherlands Amsterdam Dameri (2017); Simmie (2001); Kogler et al. (2016) 
Eindhoven Kogler et al. (2016) 
 
Kogler et al.(2016) Rotterdam 
The Hague Mayer et al. (2016) 
Wagenigen Kogler et al. (2016) 
Poland Various Nijkamp (2016) 
Sweden Malmö Makkonen and Weidenfeld (2016) 
Switzerland Bern Mayer et al. (2016) 
United 
Kingdom 
100 largest (ex. 
London) Cowling and Lee (2017) 
Cambridge Viitanen (2016) 
Coventry Athey et al. (2008) 
 
Athey et al. (2008) Dundee 
Leeds Devins et al. (2016) 
London Athey et al. (2008); Simmie (2001) 
Newcastle Couchman et al. (2008) 
Reading Athey et al. (2008) 
Various Various  Capello et al. (2012); Sáez and Periáñez (2015) 
Table 1   European (secondary) capital cities, country assignments, and coverage included within articles. 
In addition to these academic works, two practical studies are considered to be further knowledge sources 




the Regional Innovation Scoreboard (European Commission 2016a) and the European City Report (European 
Commission 2016b). These two studies provide a rich source of information based on time series and 
longitudinal data. Besides the comparison of certain variables, these reports also offer examples of policies 
that have worked. To this extent, all articles and reports together provide considerable information on cities’ 
innovation ecosystems in general and, in more detail, on the economic and political dynamics as well as the 
policy regime inside the systems. Combining all these perspectives into an analysis allows for identification 
of the particular urban factors that support or impede innovative activity of cities, as they are critical to 






On the basis of the aforementioned sources, we propose a consolidated set of 43 determinants reflecting cities’ 
local innovation ecosystems. All determinants of this set are classified and categorized along the taxonomy of 
Proksch et al. (2017). Overall, these variables illustrate the interplay of firms, markets, assets, institutions, and 
networks within a systemic architecture designed for knowledge production, consumption, and 
commercialization. In this sense, most of the established determinants introduced by Furman et al. (2002), 
extended and updated by Proksch et al. (2017), are also valid for cities’ innovation ecosystems. Only the 
intellectual strength of protection for IP and openness to international trade indicators seem to be conditions 
attributed solely to the country level and therefore not transferable to the city level. 
Further determinants have been added to create an image as holistic as possible of cities’ innovation 
ecosystems. At its core, the enhancement builds on both the basic characteristics of cities (spatial concentration 
and agglomeration) and major trends influencing a city’s development (globalization, digitalization, and 
demographical change). Appendix 1, Table 1 offers a list of the proposed city-level determinants together with 
an in-depth explanation for each item. The influence of these determinants on the outcome variable (patents) 
needs to be tested, regardless of their treatment within other studies of national or sub-national innovation 
systems. The suggested comparative method (fsQCA) would provide such a test, as the resulting pathways 
consist of only those antecedent conditions that have had a measurable impact on the outcome condition 
(patents). In this context, respective data sources per determinant have to be identified. Even though data 
availability is a well known issue in innovation system research, scholars should exclude variables sparingly, 
as exclusion might lead to an undervaluation of the respective category within the whole construct.  
4. 1     Discussion and Implications 
Although certain determinants can be used to reflect and understand a city’s innovation ecosystem, the process 
of innovation in cities remains a complex phenomenon. Naturally, cities have evolved differently, and thus 
have different preconditions for future growth. However, regardless of their developmental trajectories, 
competitiveness and innovative capacity are somehow comparable among cities. Various benchmarking 
studies offer an elevated view of the innovative performance of cities, assigning them to well known groups 
such as innovation leaders, innovation followers, moderate innovators, and modest innovators (see, for 




development, is path-dependent. Different innovation strategies with the same outcome exist, allowing cities 
to define appropriate policies in line with their specific preconditions. Evolutionary economics argues that 
international knowledge exchange and the oligopolistic power exercised by firms are the cornerstones for 
unleashing innovative activity for the first time and defending innovation ecosystems from becoming locked 
into entrenched paths in the long run, thus maintaining the preconditions for a steady growth of all factors 
concerned with innovative capacity (Simmie 2001). In this sense, path dependence can be understood as means 
of explanation for different levels of innovative capacity. Following Porter (1990), one approach would be to 
“focus on the attributes that lead to the establishment of competitive industrial production clusters” (Simmie 
2001, p. 42). Another approach, recommended by Krugman (2002), would be to emphasize “the importance 
of trade in producing external economies and agglomeration” (Simmie 2001, p. 42). In the end, no particular 
approach is right or wrong. Innovation emanates from both endogenous and exogenous factors, whose effect 
on innovative capacity is either increasing (e.g., the presence of key technologies) or decreasing (e.g., a lack 
of specialists owing to demographic change as well as unresolved questions of business succession). 
Innovative ecosystems of cities cannot be treated and analyzed hermetically, since no clear-cut innovation 
ecosystem exists in cities. As we know today, innovative capacity and entrepreneurial capacity are inextricably 
linked. Hence, the system’s boundaries are dynamic rather than static. The objective, however, is to understand 
innovation in cities as a crucial economic power promoting countries’ economic growth and development. 
Ultimately, institutional innovation, political innovation, and technical innovation are of equal relevance. To 
this end, partnerships between local places and the national government are critical prerequisites to inform the 
development of innovation policy from different perspectives, giving consideration to innovative inputs such 
as the concentration of knowledge workers as well as outputs such as new products, services, or even firms.  
Fixing certain determinants to reflect a city’s innovation ecosystem, even if they are broadly selected to 
capture the above-mentioned links, inevitably leads to the analysis of a closed system. However imperfect, 
such a system at least illustrates urban planning and evaluation processes attributed to innovative capacity and 
reveals the connections between different types of innovation. The results of a pathway analysis would enable 
policymakers responsible for urban development and sub-regional stakeholders involved in strategy 
implementation to identify promising areas of further knowledge development and smart specialization. 




metro) is critical to successfully transforming the parameters of all local innovation ecosystems within a 
country into institutional arrangements on the upper levels. 
4.2     Limitations and Future Research 
The above observations and the knowledge about the right city parameters lead to the conclusion that the 
framework proposed by Proksch et al. (2017) is transferable to city cases. Taking the proposed 43 parameters 
as a starting point, further quantitative research, ideally based on a comparative method, could determine the 
pathways leading to a high innovative capacity in cities. However, not all facets of innovation in cities can be 
reflected by variables. The well-known issues regarding patent statistics as a measure of innovative capacity 
are just the tip of the iceberg. Few studies offer fully tested determinants, and the academic quality of these 
works differs. Datasets largely build on estimations and algorithms, which from a methodical perspective do 
not result in reliable real-world observations. Hence, a major challenge for future quantitative research in this 
field will be finding appropriate data sources. A source comparable to Eurostats (Eurostats 2017) on the 
country level is not presently available for cities. However, the European Union has recently launched an 
internet-based Urban Data Platform (European Commission 2017) offering a rich load of determinants 
attributed to city comparison that might be a promising foundation for future research in this field. As similar 
resources may become available before long, covering different geographies (e.g., cities within OECD 





Table 1. List of the proposed city level determinants together with explanations 
Variable Name Numerator Denominator Rationale 
Included in 





patents (per million 
inhabitants) 
Patent applications 
to the European 
Patent Office by 
priority year, i.e. 
the year of the first 
international filing 
of a patent  
Inhabitants 
(millions) 
The capacity of firms to develop new products 
determines their competitive advantage. One indicator 
of the rate of new product innovation is the number of 
patents (European Commission 2016a). The innovative 
capacity of cities is underlined by the number of patents 
per inhabitant (European Commission 2016b). 




Quality of the common innovation infrastructure 






This is indicator denotes whether a city is more or less 
economically successful (Sáez and Periáñez 2015). 
Yes (Makkonen and 
Weidenfeld 2016; 








Time period This indicator reflects the state of the cities’ knowledge 
economy and relatedly the intensity of knowledge 
linkages and networks within regions (Makkonen and 
Weidenfeld 2016). 
Yes (Makkonen and 
Weidenfeld 2016; 
Kogler et al. 2016) 
Population Total inhabitants 
per 1 January 
Per year Population is an attractor of company head offices and 
generally has important historical and cultural legacies 
that may affect an individuals' locational decision 
(Cowling and Lee 2017). 
Yes (Cowling and Lee 
2017) 
People born abroad 
(%) 
Share of people 
born abroad 
(another country) 
Inhabitants This is a measurement of diversity and independency as 
part of socio-cultural (or societal) development 
(Makkonen and Weidenfeld 2016). Diversity is  
important in attracting talented workers who might 
prefer tolerant areas (Cowling and Lee 2017). 
No (Makkonen and 
Weidenfeld 2016; 













Inhabitants This is a general indicator of the supply of advanced 
skills. It is not limited to science and technical fields, 
because the adoption of innovations in many areas, in 
particular in the service sectors, depends on a wide 
range of skills (European Commission 2016a). The 
basic talent measure is simply the proportion of the 
adult population with an undergraduate degree and 
above (Cowling and Lee 2017). 




Cowling and Lee 
2017; Sáez and 
Periáñez 2015) 
Students Number of 
enrolled students  
Annual average Additional measure of talent. Included are students 
across all types of tertiary education. 
No (Cowling and Lee 









-/- A number of public institutions and actors support 
innovation—notably universities, individual change 
agents and some economic development agencies 
(Athey et al. 2008). As with science parks, there may be 
templates and exemplars that are promoted by 
policymakers, academics, and consultants but specific 
local configurations of institutions and governance 
relations lead to different outcomes (Couchman et al. 
2008). 
No (Athey et al. 2008; 








Share of employed 











The share of employment in high technology 
manufacturing sectors is an indicator of the 
manufacturing economy that is based on continual 
innovation through creative, inventive activity. The use 
of total employment gives a better indicator than using 
the share of manufacturing employment alone, since the 
latter will be affected by the relative decline of 
manufacturing in some countries. Knowledge-intensive 
services can be provided directly to consumers, such as 
telecommunications, and provide inputs to the 
innovative activities of other firms in all sectors of the 
economy. The latter can increase productivity 
throughout the economy and support the diffusion of a 
range of innovations, in particular those based on ICT. 
(European Commission 2016a) 
Yes (Zitek and Klimova 
2016; European 
Commission 2016a; 
















See Private R&D Funding and Percentage of R&D 
performed by universities. 






















This indicator measures non-R&D innovation 
expenditure as percentage of total turnover. Several of 
the components of innovation expenditure, such as 
investment in equipment and machinery and the 
acquisition of patents and licenses, measure the 
diffusion of new production technology and ideas 
(European Commission 2016a). 
No (European 
Commission 2016a) 





Firms are the key innovators, and cities support 
innovation by firms in a number of ways (Athey et al. 
2008). 
No (Athey et al. 2008) 





Strength of locational policy environment to support 
innovation, with regard to:  
• adapting national policy frameworks; 
• attracting funding (incl. council tax bill); 
• inducing cross-sectoral clusters; 
• incentivizing collaboration. 
No (Mayer et al. 2016; 





Share of public 





Measure of the intensity of human capital investment. A 
high level of higher education share creates a base of 
highly skilled personnel upon which ficre and other 
institutions across the economy can draw, both for 
formal R&D activities as well as other innovation-
related activities (Furman et al. 2002). 
Yes (Makkonen and 
Weidenfeld 2016) 
Cluster-specific innovation environment 
Private R&D 
Funding (%) 







This indicator captures the formal creation of new 
knowledge within firms. It is particularly important in 
the science-based sector (pharmaceuticals, chemicals 
and some areas of electronics) where most new 
knowledge is created in or near R&D laboratories 
(European Commission 2016a). 








Share of high-tech 
patent 
applications to the 




the EPO by 
priority year 
An essentially positive relationship exists between 
specialization in high-tech sectors and innovation 
performance (Capello et al. 2012). Furthermore, 
specialization degree is a measure capturing an 
important consequence of cluster dynamics, the relative 
specialization of an economy in specific technologies 
fields (Furman et al. 2002). 
Yes (Kogler et al. 2016; 
Capello et al. 2012) 





The presence of company headquarters can be a lever of 
innovation, not only because of R&D departments but 
also because the filing address of patents is generally a 
company’s head office, regardless patents’ point of 
origin. 











This indicator measures the degree to which firms that 
have introduced any new or significantly improved 
products or production processes have innovated in-
house. Innovative firms with in-house innovation 
activities have introduced a new product or new process 
either in-house or in combination with other firms. The 
indicator does not include new products or processes 








Share of firms 




innovation to one 




The Community Innovation Survey mainly asks 
enterprises about their technological innovation. Many 
enterprises, in particular in the services sectors, innovate 
through other non-technological forms of innovation. 
Examples of these are marketing and organizational 
innovations. This indicator captures the extent that firms 
innovate through non-technological innovation 
(European Commission 2016a). 
No (European 
Commission 2016a) 
Product or process 
innovators (%) 
Share of firms 
that introduced a 
new product or a 
new process to 





Technological innovation, as measured by the 
introduction of new products (goods or services) and 
processes, is a key ingredient to innovation in 
manufacturing activities. Higher shares of technological 
innovators should reflect a higher level of innovation 












Proportion of the 
total business 








Regions hosting large urban areas are the most 
innovative, and this statement is reinforced in regions 
characterized by specialization in knowledge-intensive 
services. The simultaneous presence of advanced 
manufacturing and knowledge-intensive service 
activities generates synergic effects, fostering 
innovative performance (Capello et al. 2012). 
No (Cowling and Lee 











Business space is a critical urban asset in supporting 
innovation. Both underutilization and full utilization are 
important indicators with regard to factor availability 
and suitability. 
No (Simmie 2001; 
Athey et al. 2008) 
Quality of linkages 
R&D performed by 
universities (%) 
Share of R&D 
expenditures in 
the higher 




R&D expenditure represents one of the major drivers of 
economic growth in a knowledge-based economy. 
Trends in the R&D expenditure indicator provide key 
indications of the future competitiveness and wealth of 
a region. Research and development spending is 
essential for making the transition to a knowledge-based 
economy as well as for improving production 
technologies and stimulating growth. 







-/- A given common innovation infrastructure results in a 
more productive flow of innovative output when there 
are mechanisms or institutions, such as … established 
funding sources for new ventures, which encourage the 
commercialization of new technologies in particular 
clusters. (Furman et al. 2002) Included are private 
equity transactions across these development phases: 
acquisition, preparation, founding and post-formation. 
Yes (Simmie 2001) 
New businesses 
registered (%) 





One measure of openness and vibrancy is the inflow of 
new entrepreneurial businesses as entrepreneurs start 
new firms to take advantage of perceived new market 
opportunities and gaps in the provision of goods and 
services (Cowling and Lee 2017). 

















Number of new 
businesses 
registered 
Another innovation ecosystem element is in the 
incubation environments, which provide essential, 
professional growth services for startups and growing 
SMEs. These incubation environments are physical 
locations where a selected group of young companies 
receive professional support for their management 
concerns. Included are all accelerators, incubators, idea 
labs, co-working spaces and brain trusts. 










(either digital or 
analogue) 
-/- Projects, programs or platforms promoting collaborative 
user-driven methods and tools for improving the real 
world development of products and services. Typical 
examples of these platforms include interconnected 
parts of user-driven cities, real-life experimentation sites 
on streets, open system platforms for developing mobile 
applications (with users), and internet-based, end-user 
beta-testing environments to engage users in an early-
stage R&D process. (Viitanen 2016) 
No (Anttiroiko 2016; 
Athey et al. 2008; 
Viitanen 2016) 
Internet users (%) Share of people 
who regular use 
internet 
Population The internet is a ubiquitous access point to innovation 
and creativity platforms as well as to economic 
opportunities. 








-/- These partnerships reflect the shared public/private 
interest of planning innovation activities to support the 
creation of intellectual property and cross-sectoral 
collaboration together (Viitanen 2016). 











This indicator measures the degree to which firms are 
involved in innovation co-operation. Complex 
innovations often depend on companies' ability to draw 
on diverse sources of information and knowledge, or to 
collaborate on the development of an innovation. This 
indicator measures the flow of knowledge between 
public research institutions and firms, and between 
firms and other firms. Firms with co-operation activities 
are those that have had any co-operation agreements on 

















Complement to stock of international patents. 
Scientific publications indicate the knowledge 
infrastructure (science base) of a city.  
Yes (Makkonen and 
Weidenfeld 2016; 








-/- Complement to educational attainment rate (%). 
Research has highlighted considerable difference in 
labor markets between university and non-university 
cities. Some cities have universities that were founded 
hundreds of years ago and are woven into the culture of 
a city as well as being a major actor in the socio-
economic system of a city (Cowling and Lee 2017). 
Especially cities hosting universities that enjoy a strong 
reputation in the offered scientific disciplines might be 
relevant for the acquisition of both new talent and high 
qualified labor (Makkonen and Weidenfeld 2016). 
No (Makkonen and 
Weidenfeld 2016; 
Cowling and Lee 
2017) 
Spoken languages Number of 
foreign languages 
spoken 
 -/- Complement to educational attainment rate (%). 
Language barriers restrict international labor mobility. 






persons engaged  
Annual average Complement to employment in medium-high and high-
tech manufacturing and knowledge-intensive services. 
Innovative capacity depends in part on the 
labor force of an economy.  
Yes (Sáez and Periáñez 
2015) 
Job change rate Mean length of 
stay in the same 
job 
Time period Complement to firms innovating in-house (%). 
This indicator measures the duration of transferring 
exclusive knowledge among firms and organizations 
driven by job changes (i.e. the “rotation” of labor). 








-/- Complement to GDP per capita.  
Measure of economic development. 





capital stock  
-/- Complement to GDP per capita.  
Measure of economic development. 












Complement to head offices (%). 
This indicator signals how well the labor markets of the 
cities and regions are integrated. 









Share of people in 







Complement to population. 
This indicator is used to measure the pressure on 
productive population. 
No (Makkonen and 
Weidenfeld 2016) 






Complement to population. 
Quality of life and place, aggregated measure consisting 
of the following sub-categories: 
• Agglomeration economies (e.g., population density) 
• Attractive environments (e.g., CO2 emissions) 
• High quality facilities (e.g., public transport) 
• Cultural diversity (e.g., arts, cuisine, religion) 
• Welfare (cost of living) 
• Safety (crimes involving life and death) 
• Healthcare infrastructure (e.g., hospitals) 
No (Simmie 2001; 
Makkonen and 
Weidenfeld 2016; 
Cowling and Lee 
2017; Sáez and 
Periáñez 2015) 
Ethnic groups Number of 
different ethno-
linguistic groups  
 Complement to share of people born abroad (%).  
The measure of diversity refers to the ethnic diversity of 
the population. (Cowling and Lee 2017) 
No (Cowling and Lee 
2017) 





Total exports Complement to specialization degree (%). 
The indicator measures the technological 
competitiveness of a region, i.e., its ability to 
commercialize the results of research and development 
(R&D) and innovation in the international markets. It 
also reflects product specialization. Creating, exploiting 
and commercializing new technologies are vital for the 
competitiveness of a region in the modern economy. 
Medium and high technology products are key drivers 
of economic growth, productivity and welfare, and are 
generally a source of high value added and well paid 








firm innovations (%) 
Share of total 









Complement to specialization in technology (advanced 
manufacturing and knowledge intensive services)(%.) 
This indicator measures the turnover of new or 
significantly improved products to the firm as a 
percentage of total turnover. These products are not new 
to the market. Sales of new-to-the-firm but not new-to-
the-market products are a proxy of the use or 
implementation of products (or technologies) already 
introduced elsewhere. This indicator is a proxy for the 
degree of diffusion of state-of-the-art technologies. 
No (European 
Commission 2016a) 
Capital Capital stock 
based on total 
financial assets  
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